
The civil rights leader Rev. Jesse Jackson has been hospitalized, the Rainbow PUSH Coalition announced Wednesday evening.
Jackson, 84, has been admitted to the hospital and is under observation for progressive supranuclear palsy, a neurodegenerative condition, which he has been managing for a decade, the organization said in a statement.
"The family appreciates all prayers at this time," the group said.
Jackson was originally diagnosed with Parkinson's disease, however his PSP condition was confirmed in April, the organization said.
PSP is a rare neurological disorder which affects body movements, walking and balance, and eye movements, according to the National Institutes of Health. It is caused by damage to nerve cells in parts of the brain.
Jackson, a protege to the Rev. Martin Luther King Jr. who rose to prominence as one of the nation's foremost civil rights leaders and twice ran for U.S. president, stepped down in 2023 from the leadership of the Rainbow PUSH Coalition, which he founded.
LATEST POSTS
- 1
How Trump's marijuana executive order could change medical research landscape - 2
Figure out how to Use Your Brain research Degree in the Gig Market - 3
The most effective method to Stay away from Normal Traps While Recruiting a Material Organization - 4
RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt - 5
NASA's Voyager 1 set to achieve historic distance from Earth
Going on a bad date is a drag. Worse? Ending up as a cautionary tale on TikTok.
US bishops officially ban gender-affirming care at Catholic hospitals
Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
5 Home EV Chargers for Proficient and Solid Charging
Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
Vacation destinations in America
Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
Chicago reports first rabies-positive dog in 61 years. What we know.
Moderna to complete US mRNA manufacturing network with $140 million investment













